Next Generation Dx Summit

Speakers

Next Generation Dx Summit 2014 – Speaker List Speaker Biographies 

Gyorgy Abel, M.D., Ph.D., Director, Molecular Diagnostics, Immunology & Clinical Chemistry, Laboratory Medicine, Lahey Hospital & Medical Center

Edward Abrahams, Ph.D., President, Personalized Medicine Coalition

Chong H. Ahn, Ph.D., Mitchell P. Kartalia Chair and Professor, Microsystems and BioMEMS Laboratory, School of Electronics and Computing Systems, University of Cincinnati

Randy Allen, Ph.D., Director, Global Markets Team, Clinton Health Access Initiative (CHAI)

Sami S. Amr, Ph.D., Instructor, Pathology, Harvard Medical School; Director, PCPGM Research Core; Assistant Director, Lab for Molecular Medicine, Partners Center for Personalized Genetic Medicine

Philipp Angenendt, Ph.D., Director, Global Operations, Sysmex Inostics GmbH

Mike Barlow, Vice President, Palmetto GBA

J. Carl Barrett, Ph.D., Vice President, Translational Sciences, Onc iMed, AstraZeneca

Lora J.H. Bean, Ph.D., F.A.C.M.G., Assistant Professor, Senior Director, Molecular Diagnostic Laboratory, Emory Genetics Laboratory, Human Genetics, Emory University

Holger Becker, Ph.D., Founder & CSO, microfluidic ChipShop GmbH

Chetan Bettegowda, M.D., Ph.D., Assistant Professor, Neurological Surgery, Johns Hopkins University School of Medicine

Mark S. Boguski, M.D., Ph.D., Associate Professor, Pathology, Center for Biomedical Informatics, Harvard Medical School

Robert A. Bonomo, M.D., Chief, Medical Service, Louis Stokes Cleveland VA Hospital; Vice Chair, Veterans Affair, Medicine, University Hospital Case Medical Center

Jeff Boyd, Ph.D., Senior Vice President, Molecular Medicine; The Robert C. Young, M.D., Chair in Cancer Research; Executive Director, Cancer Genome Institute; Chief, Division of Molecular Pathology; Professor, Cancer Biology Program, Fox Chase Cancer Center

Roslyn Brandon, Ph.D., CEO and Co-Founder, Immunexpress 

Catherine Brownstein, M.D., Instructor, Pediatrics, Harvard Medical School and Boston Children’s Hospital

Tracy Bush, Ph.D., Director and Global Coordinator, Companion Diagnostics, Regulatory Affairs, Roche Diagnostics

Lon Castle, M.D., Medical Science Liaison, Medical Affairs, CardioDx

Rong Chen, Ph.D., Assistant Professor, Genetics and Genomic Sciences; Director, Clinical Genome Informatics, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai

Charles Chiu, M.D., Ph.D., Assistant Professor, Lab Medicine and Medicine, Infectious Diseases, University of California San Francisco Melina Cimler, Ph.D., Vice President, Head, Global Quality, Illumina, Inc.

John Clarkson, Chief Executive, Atlas Genetics Ltd.

Barbara Conley, M.D., Associate Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute

Laura Conlin, Ph.D., FACMG, Scientific Director, Division of Genomic Diagnostics, Children’s Hospital of Philadelphia; Assistant Professor, Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania

Robert Cook-Deegan, M.D., Research Professor, Institute for Genome Sciences & Policy, Sanford School of Public Policy, Duke University

Seth D. Crosby, M.D., Director, Alliances and Partnerships, Genetics, Washington University School of Medicine

Robert D. Daber, Ph.D., Director, Research and Development and Sequencing Operations, Bio-Reference Laboratories

Shahriar Dadkhah, M.D., MBA, FACC, FSCAI, Associate Professor, Medicine, University of Illinois; Director, Cardiology Research, Saint Francis Hospital

Baabi Das, MBA, President and Founder, Zansors

Luis A. Diaz, M.D., Associate Professor, Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Jennifer Dickey, RAC, Ph.D., Office of In Vitro Diagnostics, DIHD, US Food and Drug Administration

David P. Dimmock, M.D., Associate Professor, Pediatrics, Medical College of Wisconsin

Kenneth Emancipator, M.D., Director, Companion Diagnostics, Merck Research Laboratories

Mark T. Esser, Ph.D., Director, Translational Medicine, Infectious Diseases and Vaccines, MedImmune

David Erickson, Ph.D., Associate Professor, Sibley School of Mechanical & Aerospace Engineering, Cornell University

Brigitte Faas, Ph.D., Clinical Cytogeneticist, Human Genetics, Radboud University Nijmegen Medical Center

Helen Fernandes, Ph.D., Pathology & Laboratory Medicine, Weill Cornell Medical College

Carlos Gil Ferreira, M.D., Executive Director, INOVA-CANCER; Director, Clinical Research, Brazilian National Cancer Institute

Thomas M. File, Jr. M.D., MSc, MACP, FIDSA, FCCP, Chair, Infectious Disease Division, Summa Health System; Professor, Internal Medicine; Master Teacher; Chair, Infectious Disease Section, Northeast Ohio Medical University (NEOMED)

Andrew C. Fish, Executive Director, AdvaMedDx

Eric Fung, M.D., Ph.D., Vice President, Research and Development, Clinical Applications, Affymetrix  

David W. Gee, Partner, Davis Wright Tremaine LLP

Jeremy Goecks, Ph.D., Assistant Professor, Computational Biology, Integrative Systems Biology and The Computational Biology Institute, George Washington University

Wayne W. Grody, M.D., Ph.D., Professor, Medical Genetics and Molecular Pathology, Pathology & Lab Medicine, Pediatrics, and Human Genetics; Director, Molecular Diagnostic Laboratories and Clinical Genomics Center, UCLA School of Medicine

John W. Hanna, Senior Director, Policy & Reimbursement, Veracyte

Kevin M. Harter, President and CEO, Saladax Biomedical

Matthew J. Hawryluk, Ph.D., Senior Director, Corporate & Business Development, Foundation Medicine, Inc.

Madhuri Hegde, Ph.D., FACMG, Associate Professor, Human Genetics; Executive Director, Emory Genetics Laboratory, Emory University School of Medicine

Michael J. Heller, Ph.D., Professor, Nanoengineering & Bioengineering, University of California San Diego

James Hicks, Ph.D., Research Professor, Cancer Genomics, Cold Spring Harbor Laboratory

Mark Hills, Ph.D., Research Scientist, Peter M. Lansdorp Laboratory, BC Cancer Research Centre

David Himsworth, Director, Clinical Affairs, Luminex Corporation

Dave S. B. Hoon, MSc, Ph.D., CSI & Director, Molecular Oncology; Director, JWCI Sequencing Center, John Wayne Cancer Institute

Patric Hooper, Founding Partner, Hooper, Lundy & Bookman, PC

Joany Jackman, Ph.D., Investigator, Center for Point of Care Tests for STD, Johns Hopkins University School of Medicine

Pawan K. Jain, M.D., Ph.D., Senior Regulatory Scientist, Division of Emerging and Transfusion Transmitted Disease, Office of Blood Research and Review, Center for Biologics Evaluation Research, FDA

David James, Senior Vice President, IVD Division, Invetech

François Jean, Ph.D., Scientific Director, UBC Facility for Infectious Disease and Epidemic, Research (FINDER); Associate Professor, Microbiology and Immunology, Laboratory for Antimicrobial Therapy, University of British Columbia

Andreas Jeromin, Scientific and Medical Advisor, Quanterix Corporation

Shana Kelley, Ph.D., Chief Technology Officer, Xagenic Inc. 

Muin J. Khoury, M.D., Ph.D., NCI Epidemiology and Genomics Research Program, CDC Office of Public Health Genomics

Scott Kopetz, M.D., Ph.D., Associate Professor, Gastrointestinal Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center

Bruce Korf, M.D., Ph.D., Wayne H. and Sara Crews Finley Chair, Medical Genetics; Professor and Chair,Genetics; Director, Heflin Center for Genomic Sciences, University of Alabama at Birmingham Matthew Kreifels, Manager, Molecular Technology, Streck, Inc.

Parveen Kumar, Research Scientist, Thierry Voet Laboratory, Human Genetics, University of Leuven

Eric Lai, Ph.D., Senior Vice President & Head, Pharmacogenomics, Takeda Pharmaceuticals

Melissa J. Landrum, Ph.D., Staff Scientist, NIH/NLM/NCBI

Nathan A. Ledeboer, Ph.D., D(ABMM), Assistant Professor & Medical Director, Clinical Microbiology, Medical College of Wisconsin

Nicholas J. Lench, Ph.D., FRCPath, Director, NE Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust

Jorge A. Leon, Ph.D., President & CEO, Leomics Associates, Inc.

Zhenyu Li, Ph.D., Assistant Professor, School of Engineering and Applied Science, George Washington University

Matthew Lorence, Ph.D., MBA, TessArae, LLC

Rajyalakshmi Luthra, Ph.D., Director, Molecular Diagnostic Laboratory (MDL) and Molecular Genetic Pathology Fellowship Program; Medical Advisor, Molecular Genetic Technology Program, School of Health Professions; Professor, Hematopathology, The University of Texas MD Anderson Cancer Center

Elaine Lyon, Ph.D., Medical Director, Molecular Genetics, ARUP

Sabah Malek, Associate Director, Global Regulatory Affairs, Eisai, Inc.

Jomol Mathew, Ph.D., Director, Clinical and Translational Informatics, IS, Dana-Farber Cancer Institute

Michael Masterman-Smith, Ph.D., Entrepreneurial Scientist, UCLA California NanoSystems Institute

Thomas May, Ph.D., Associate Professor, Bioethics and Medical Humanities; Director, Graduate Program in Bioethics, Center for Bioethics and Medical Humanities, Medical College of Wisconsin

Raja Mazumder, Ph.D., Associate Professor, Biochemistry and Molecular Biology, George Washington University

Daniel McClernon, President, CSO, Virology, bioMONTR Labs

Heather McLaughlin, Ph.D., MB(ASCP)CM, Instructor of Pathology, Massachusetts General Hospital and Harvard Medical School and Assistant Laboratory Director, Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine

Christine Micheel, Ph.D., Research Assistant Professor, Medicine, Vanderbilt-Ingram Cancer Center; Managing Editor, MyCancerGenome.org

Glenn A. Miller, Ph.D., CTO & Executive Vice President, Molecular MD

Jennifer Morrissette, Ph.D., Scientific Director, Clinical Cytogenetics Laboratory; Clinical Director, Center for Personalized Diagnostics (CPD), University of Pennsylvania Perelman School of Medicine

Muhammed Murtaza, MBBS, Research Assistant Professor and Co-Leader, Program in Circulating Nucleic Acids, TGen, Translational Genomics Research Institute

Jerod Nagel, Pharm.D., BCPS (AQID), Clinical Specialist, Infectious Diseases, Clinical Assistant Instructor, Director Infectious Diseases Residency, University of Michigan Hospital and Health Systems, University of Michigan, College of Pharmacy

Peter Nagy, Ph.D., Director, Clinical Next-Generation Sequencing Lab; Assistant Professor, Pathology and Cell Biology, Columbia University

Peter Nemes, Ph.D., Assistant Professor, Chemistry, George Washington University

Susan M. Novak-Weekley, Ph.D., D(ABMM), Director, Microbiology, Kaiser Permanente, SCPMG Regional Reference Laboratories

Frank S. Ong, M.D., Associate Director, Medical Affairs, Illumina, Inc.

Aydogan Ozcan, Ph.D., Chancellor’s Professor, Electrical Engineering and Bioengineering, University of California Los Angeles; Associate Director, California NanoSystems Institute (CNSI)

David Parker, Ph.D., Vice President, Market Access Strategy, Precision for Medicine

Donald “Will” Parsons, M.D., Ph.D., Assistant Professor, Pediatrics, Molecular & Human Genetics, Baylor College of Medicine, Texas Children’s Cancer Center

Robin Patel, M.D.(CM), FRCP(C), D(ABMM), FIDSA, FACP, F(AAM), Chair, Clinical Microbiology; Consultant, Clinical Microbiology and Infectious Diseases; Professor, Microbiology and Medicine, College of Medicine, Mayo Clinic

Donna Polizio, Associate Director, Government Accounts, Genomic Health

Jason C. Poole, Ph.D., Director, R&D, Trovagene, Inc.

Kristin Ciriello Pothier, Partner/Principal, Ernst and Young

Nick Poulios, Ph.D., Head, MORE, Medical Outcomes: Reimbursement & Economics, Roche Molecular Systems, Inc.

Aniruddha Puntambekar, Ph.D., Executive Vice President, Siloam Biosciences, Inc.

John Quackenbush, Ph.D., Co-Founder and CEO, GenoSpace; Professor, Dana-Farber Cancer Institute and Harvard School of Public Health, Biostatistics and Computational Biology

Erica Ramos, MS, CGC, Clinical Genomics Specialist, Certified Genetic Counselor, New and Emerging Opportunities, Illumina, Inc.

Mitch Raponi, Senior Director, Molecular Diagnostics & Translational Medicine, Clovis Oncology

David A. Rasko, Ph.D., Associate Professor, Microbiology & Immunology, University of Maryland School of Medicine Institute for Genome Sciences

Vincent Ricchiuti, Ph.D., Associate Professor, Director, Clinical Chemistry and Toxicology, Department of Pathology and Laboratory Medicine, UC Health University Hospital

Greg Richard, Senior Vice President & General Manager, Interpace Diagnostics, PDI, Inc.  

Katherine Richardson, Vice President, R&D, Transgenomic

Marc Salit, Ph.D., Genome-Scale Measurements Group Leader, National Institute of Standards and Technology

Carol Saunders, Ph.D., FACMG, Director, Molecular Genetics Laboratory, Department of Pathology & Laboratory Medicine; Associate Professor, Department of Pathology, UMKC School of Medicine, Children’s Mercy Hospital

Mark Sausen, Ph.D., Director, R&D, Personal Genome Diagnostics

Heinz Schimmel, Ph.D., Scientific Officer, Standards for Innovation and Sustainable Development (SID), European Commission - Joint Research Centre (JRC)

Hemanth Shenoi, Ph.D., Director, Business Development, Lucigen Corporation

Vahan Simonyan, Ph.D., HIVE Project Lead, CBER, FDA

Denis Smirnov, Associate Scientific Director, US Biomarker Oncology, Janssen R&D US 

Judi Smith, Vice President, In Vitro Diagnostics and Quality, Precision for Medicine

Matthew Snyder, Graduate Student, Genomic Sciences, University of Washington

Richard St. Clair, Vice President, Commercialization, Evogen Inc.

Gregory Storch, M.D., Ruth L. Siteman Professor of Pediatrics, Director, Divisions of Pediatric Infectious Diseases and Pediatric Laboratory Medicine, Washington University School of Medicine; Medical Director of Clinical Laboratories, St. Louis Children’s Hospital

Michael Super, Ph.D., Senior Staff Scientist, Advanced Technology Team, Wyss Institute at Harvard

W. Fraser Symmans, M.D., Professor & Director, Research Operations, Department of Pathology, UT MD Anderson Cancer Center

AmirAli Talasaz, Ph.D., President & CTO, Guardant Health, Inc.

Živana Težak, Ph.D., Associate Director, Science and Technology, Personalized Medicine, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), Center for Devices and Radiological Health (CDRH), FDA

Alain R. Thierry, Ph.D., Senior Investigator, Research Institute in Oncology of Montpellier, INSERM

Ali Tinazli, Ph.D., Director & Head, Business Development & Sales, Sony DADC BioSciences, Sony DADC

Peter J. Tonellato, Ph.D., Director, Laboratory for Personalized Medicine, Center for Biomedical Informatics, Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School

Ephraim L. Tsalik, M.D., MHS, Ph.D., Assistant Professor, Medicine, Division of Infectious Diseases, Institute for Genome Sciences & Policy, Duke University Medical Center

Sean R. Tunis, M.D., MSc, Founder & Director, Center for Medical Technology Policy

Eric van Gieson, Ph.D., R&D Director, Diagnostics and Biosurveillance, MRIGlobal

Victor E. Velculescu, M.D., Ph.D., Professor, Oncology; Co-Director, Cancer Biology, Johns Hopkins Kimmel Cancer Center

Vickie L. Venne, MS, LGC, Senior Genetic Counselor, Genomic Medicine Service, Department of Veterans Affairs, VA Salt Lake City Health Care System

Jan Vijg, Ph.D., Professor and Chairman, Genetics, Albert Einstein College of Medicine

Gene Walther, MBA, Deputy Director Diagnostics, Global Health, Bill & Melinda Gates Foundation

Yong Wang, Ph.D., Research Scientist, Nicholas E. Navin Laboratory, Genetics, Bioinformatics, MD Anderson Cancer Center

Anton Wellstein, M.D., Ph.D., Professor, Oncology, Pharmacology and Medicine, Georgetown University Medical School; Associate Director, Basic Science, Lombardi Comprehensive Cancer Center

Aaron Wheeler, Ph.D., Director, Wheeler Microfluidics Lab, University of Toronto

Ian White, Ph.D., Assistant Professor, Fischell Department of Bioengineering, University of Maryland

Richard A. White, Ph.D., Director, Global Strategy, Breast and Colon Products, Genomic Health, Inc.

George M. Whitesides, Ph.D., Woodford L. & Ann A. Flowers Professor, Chemistry & Chemical Biology, Harvard University

P. Mickey Williams, Ph.D., Director, Molecular Characterization & Clinical Assay Development Laboratory (MoCha), Frederick National Laboratory for Cancer Research

Rina Wolf, Vice President, Commercialization Strategies, Consulting & Industry Affairs, XIFIN, Inc. 

Sunney Xie, Ph.D., Mallinckrodt Professor, Chemistry and Chemical Biology, Harvard University

Roman Yelensky, Ph.D., Senior Director, Biomarker and Companion Diagnostics Development, Foundation Medicine, Inc.

Benjamin Yellen, Ph.D., Associate Professor, Mechanical Engineering and Materials Science, Duke University

Asad R. Zaidi, President & CEO, Epinex Diagnostics, Inc.

Theresa Zhang, Ph.D., Vice President, Research Services, Personal Genome Diagnostics

John F. Zhong, Ph.D., Associate Professor, Pathology, University of Southern California School of Medicine

Justin Zook, Ph.D., Biomedical Engineer, National Institute of Standards and Technology

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 


2014 Brochure 


Premier Sponsors

Affymetrix 

Luminex 

Certara 



MDX_Logo_150x150